Literature DB >> 34534377

RAS induced senescence of skin keratinocytes is mediated through Rho-associated protein kinase (ROCK).

Alex J Lee1, Elise Fraser1, Brittany Flowers1, Jee Kim1, Kenneth Wong1, Christophe Cataisson1, Huaitian Liu1, Howard Yang1, Maxwell P Lee1, Stuart H Yuspa1, Luowei Li1.   

Abstract

Cellular senescence is a well-documented response to oncogene activation in many tissues. Multiple pathways are invoked to achieve senescence indicating its importance to counteract the transforming activities of oncogenic stimulation. We now report that the Rho-associated protein kinase (ROCK) signaling pathway is a critical regulator of oncogene-induced senescence in skin carcinogenesis. Transformation of mouse keratinocytes with oncogenic RAS upregulates ROCK activity and initiates a senescence response characterized by cell enlargement, growth inhibition, upregulation of senescence associated β-galactosidase (SAβgal) expression, and release of multiple pro-inflammatory factors comprising the senescence-associated secretory phenotype (SASP). The addition of the ROCK inhibitor Y-27632 and others prevents these senescence responses and maintains proliferating confluent RAS transformed keratinocyte cultures indefinitely. Mechanistically, oncogenic RAS transformation is associated with upregulation of cell cycle inhibitors p15Ink4b , p16Ink4a , and p19Arf and downregulation of p-AKT, all of which are reversed by Y-27632. RNA-seq analysis of Y-27632 treated RAS-transformed keratinocytes indicated that the inhibitor reduced growth-inhibitory gene expression profiles and maintained expression of proliferative pathways. Y-27632 also reduced the expression of NF-κB effector genes and the expression of IκBζ downstream mediators. The senescence inhibition from Y-27632 was reversible, and upon its removal, senescence reoccurred in vitro with rapid upregulation of cell cycle inhibitors, SASP expression, and cell detachment. Y-27632 treated cultured RAS-keratinocytes formed tumors in the absence of the inhibitor when placed in skin orthografts suggesting that factors in the tumor microenvironment can overcome the drive to senescence imparted by overactive ROCK activity. Published 2021. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  RAS; ROCK; keratinocytes; oncogene; senescence

Mesh:

Substances:

Year:  2021        PMID: 34534377      PMCID: PMC8585695          DOI: 10.1002/mc.23351

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   5.139


  57 in total

1.  Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation.

Authors:  A W Lin; S W Lowe
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

2.  ER stress and distinct outputs of the IRE1α RNase control proliferation and senescence in response to oncogenic Ras.

Authors:  Nicholas Blazanin; Jeongin Son; Alayna B Craig-Lucas; Christian L John; Kyle J Breech; Michael A Podolsky; Adam B Glick
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-28       Impact factor: 11.205

3.  mTORC1 loss impairs epidermal adhesion via TGF-β/Rho kinase activation.

Authors:  Kaushal Asrani; Akshay Sood; Alba Torres; Dan Georgess; Pornima Phatak; Harsimar Kaur; Amber Dubin; C Conover Talbot; Loubna Elhelu; Andrew J Ewald; Bo Xiao; Paul Worley; Tamara L Lotan
Journal:  J Clin Invest       Date:  2017-09-25       Impact factor: 14.808

4.  Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence.

Authors:  Akiko Takahashi; Naoko Ohtani; Kimi Yamakoshi; Shin-ichi Iida; Hidetoshi Tahara; Keiko Nakayama; Keiichi I Nakayama; Toshinori Ide; Hideyuki Saya; Eiji Hara
Journal:  Nat Cell Biol       Date:  2006-10-08       Impact factor: 28.824

5.  CXCR2 ligands and G-CSF mediate PKCalpha-induced intraepidermal inflammation.

Authors:  Christophe Cataisson; Andrea J Pearson; Margaret Z Tsien; Francesca Mascia; Ji-Liang Gao; Saveria Pastore; Stuart H Yuspa
Journal:  J Clin Invest       Date:  2006-09-07       Impact factor: 14.808

6.  Human keratinocytes are efficiently immortalized by a Rho kinase inhibitor.

Authors:  Sandra Chapman; Xuefeng Liu; Craig Meyers; Richard Schlegel; Alison A McBride
Journal:  J Clin Invest       Date:  2010-07       Impact factor: 14.808

7.  Smad3 regulates senescence and malignant conversion in a mouse multistage skin carcinogenesis model.

Authors:  Kinnimulki Vijayachandra; Jessica Lee; Adam B Glick
Journal:  Cancer Res       Date:  2003-07-01       Impact factor: 12.701

8.  Growth stimulation leads to cellular senescence when the cell cycle is blocked.

Authors:  Zoya N Demidenko; Mikhail V Blagosklonny
Journal:  Cell Cycle       Date:  2008-11-12       Impact factor: 4.534

9.  Inducible cutaneous inflammation reveals a protumorigenic role for keratinocyte CXCR2 in skin carcinogenesis.

Authors:  Christophe Cataisson; Rebecca Ohman; Gopal Patel; Andrea Pearson; Margaret Tsien; Steve Jay; Lisa Wright; Henry Hennings; Stuart H Yuspa
Journal:  Cancer Res       Date:  2009-01-01       Impact factor: 12.701

10.  Induction of p16ink4a and p19ARF by TGFbeta1 contributes to growth arrest and senescence response in mouse keratinocytes.

Authors:  Kinnimulki Vijayachandra; William Higgins; Jessica Lee; Adam Glick
Journal:  Mol Carcinog       Date:  2009-03       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.